EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia

Rossella Cirillo, Sandra Duperrier, Pathik Parekh, Mathilde Millot, Qin Li, Marie-Laure Thiolat, Micaela Morelli, Jing Xie, Didier Le Bars, Jérôme Redouté, Erwan Bezard, Véronique Sgambato

Journal of Parkinson’s Disease · 2024

DOI: 10.3233/jpd-230331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2024. Verfasst von Rossella Cirillo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut des Sciences Cognitives Marc Jeannerod (ISCMJ), Unité Mixte de Recherche 5229 du Centre National de la Recherche Scientifique (CNRS), Bron, …. Hauptthemen laut MEDLINE: Parkinson Disease, Dyskinesia, Drug-Induced, Parkinsonian Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations of serotonin type 4 receptor levels are linked to mood disorders and cognitive deficits in several conditions. However, few studies have investigated 5-HT 4 R alterations in movement disorders. We wondered whether striatal 5-HT 4 R expression is altered in experimental parkinsonism. We used a brain bank tissue from a rat and a macaque model of Parkinson’s disease (PD). We then investigated its in vivo PET imaging regulation in a cohort of macaques. Dopaminergic depletion increases striatal 5-HT 4 R in the two models, further augmented after dyskinesia-inducing L-Dopa. Pending confirmation in PD patients, the 5-HT 4 R might offer a therapeutic target for dampening PD’s symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDyskinesia, Drug-InducedParkinsonian DisordersHumansRatsAnimalsReceptors, Serotonin, 5-HT4LevodopaDisease Models, AnimalOxidopamineAntiparkinson Agents

Stichwörter der Autor:innen

L-DopaPET imagingParkinson’s diseasedyskinesiaexperimental animal modelsimmunohistochemistrymovement disordersparkinsonismserotonin

Substanzen

Receptors, Serotonin, 5-HT4LevodopaOxidopamineAntiparkinson Agents

Autor:innen und Institutionen

  • Institut des Sciences Cognitives Marc Jeannerod (ISCMJ), Unité Mixte de Recherche 5229 du Centre National de la Recherche Scientifique (CNRS), Bron, France.
  • Universitè de Lyon 1, Lyon, France.
  • Department of Biomedical Sciences, Section of Neuroscience, University of Cagliari, Monserrato, Italy.
  • Motac Beijing Services, Beijing, China.
  • Universitè de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France.
  • CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France.

Zitieren

APA

Cirillo, R., Duperrier, S., Parekh, P., Millot, M., Li, Q., Thiolat, M. L., Morelli, M., Xie, J., Le Bars, D., Redouté, J., Bezard, E., & Sgambato, V. (2024). Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230331

Vancouver

Cirillo R, Duperrier S, Parekh P, Millot M, Li Q, Thiolat ML, et al. Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia. Journal of Parkinson’s Disease. 2024. doi:10.3233/jpd-230331

BibTeX
@article{Cirillo2024,
  author = {Cirillo, Rossella and Duperrier, Sandra and Parekh, Pathik and Millot, Mathilde and Li, Qin and Thiolat, Marie-Laure and Morelli, Micaela and Xie, Jing and Le Bars, Didier and Redouté, Jérôme and Bezard, Erwan and Sgambato, Véronique},
  title = {Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  doi = {10.3233/jpd-230331}
}
Kostenlos starten →